Mark K. Oki - 17 Jan 2022 Form 3 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role: Chief Financial Officer
Signature: /s/ Josh Disbrow as attorney-in-facty for Mark K. Oki
Issuer symbol: AYTU
Transactions as of: 17 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Jan 2022, 10:40:01 UTC
Next filing: 28 Nov 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 Power of Attorney